Joseph Arron, M.D., Ph.D.

Chief Scientific Officer at Sonoma Biotherapeutics

Speaker

Joseph Arron joined Sonoma Biotherapeutics as Chief Scientific Officer in 2023, after serving as a member of Sonoma’s Scientific Advisory Board.

Previously, Dr. Arron served as CSO at 23andMe Therapeutics from 2021-2023. Prior to that, he worked at Genentech for 15 years, ultimately leading discovery research in inflammatory, autoimmune, fibrotic, and ophthalmic diseases across more than 20 laboratories. His laboratory discovered pathogenic mechanisms and molecular bases for heterogeneity in respiratory disorders, enabling target and biomarker discovery for numerous investigational molecular therapies currently approved or in clinical development.

Dr. Arron earned an undergraduate degree from Princeton University, completed a combined MD-PhD degree at Cornell University Medical College and the Rockefeller University, and conducted postdoctoral studies at Stanford University School of Medicine. He is a member of the Henry Kunkel Society and the American Society for Clinical Investigation, and has authored over 100 peer-reviewed publications.